Competing interests
Johnson and Johnson, Merck, Pfizer, and Roche
R.D. has received grants from AstraZeneca, Merck, and Pfizer; consulting fees from Merck and Pfizer; and honoraria from GSK, Merck, Pfizer, and Sanofi Pasteur. J.B.D. has received consulting fees from Sanofi; payment or honoraria from Sanofi; and has participated in data safety monitoring boards or advisory boards for AstraZeneca. S.A.M. has received grants or contracts from BMGF, GSK, Minervax, Pfizer, and the South African Medical Research Council; payments or honoraria from BMGF; and has participated in data safety monitoring boards or advisory boards for CAPRISA and PATH. E.A.S. has received grants or contracts from AstraZeneca, Johnson and Johnson, Merck, Pfizer, and Roche; consulting fees from Adiago Therapeutics, Cidara Therapeutics, Merck, Nuance Pharmaceuticals, Pfizer, and Sanofi; payment or honoraria from AstraZeneca and Pfizer; support for meeting attendance and/or travel from AstraZeneca; and has participated in data safety monitoring boards or advisory boards for Abbvie, Bill and Melinda Gates Foundation, and GSK. B.A., K.M.T., A.A.A., D.W., J.D.G., H.J., B.S., A.K., A.M.S., V.S.M., A.L., U.W.H., E.J.K., and T.V. are current employees of AstraZeneca and may hold stock or stock options. S.D.S., D.E.T., and M.E.A. are former employees of AstraZeneca.